BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38739893)

  • 21. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer.
    Gelover E; Katherine C; Mart C; Sun W; Kim Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):83-92. PubMed ID: 29349933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
    Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer.
    Otter S; Coates A; Franklin A; Cunningham M; Stewart A
    Brachytherapy; 2018; 17(3):580-586. PubMed ID: 29426744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy.
    Serban M; Kirisits C; Pötter R; de Leeuw A; Nkiwane K; Dumas I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Marthinsen ABL; Lindegaard J; Tanderup K;
    Radiother Oncol; 2018 Dec; 129(3):567-574. PubMed ID: 30243671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
    Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
    Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
    Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
    Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008.
    Majercakova K; Pötter R; Kirisits C; Banerjee S; Sturdza AE; Georg P; Nesvacil N; Schmid MP
    Acta Oncol; 2015; 54(9):1551-7. PubMed ID: 26198658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer.
    Tanderup K; Nesvacil N; Kirchheiner K; Serban M; Spampinato S; Jensen NBK; Schmid M; Smet S; Westerveld H; Ecker S; Mahantshetty U; Swamidas J; Chopra S; Nout R; Tan LT; Fokdal L; Sturdza A; Jürgenliemk-Schulz I; de Leeuw A; Lindegaard JC; Kirisits C; Pötter R
    Semin Radiat Oncol; 2020 Oct; 30(4):311-327. PubMed ID: 32828387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
    Paton AM; Chalmers KE; Coomber H; Cameron AL
    Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
    Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-center dosimetric predictions to improve plan quality for brachytherapy for cervical cancer treatment.
    Reijtenbagh DMW; Godart J; de Leeuw AAC; Jürgenliemk-Schulz IM; Mens JM; Huge M; Hoogeman MS
    Radiother Oncol; 2023 May; 182():109518. PubMed ID: 36736588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.
    Schmid MP; Fokdal L; Westerveld H; Chargari C; Rohl L; Morice P; Nesvacil N; Mazeron R; Haie-Meder C; Pötter R; Nout RA;
    Radiother Oncol; 2020 Apr; 145():36-44. PubMed ID: 31874348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.